MYB can promote T cell development, and Notch signaling has been found to enhance this effect.[17] In additional, Ning Su et al[3] analyzed 19 patients with metastatic ACC treated with anlotinib and concluded that anlotinib had good antitumor activity and controllable toxicity against metastatic ACC. The gene discussed is MYB; the disease is adrenal cortex carcinoma.